Vaccines Articles
Michigan State University researchers have created a new malaria vaccine that appears to increase the immune response against the parasite that causes the deadly disease.
The Nobel Foundation has awarded Ralph Steinman of Canada, American Bruce Beutler and Jules Hoffmann of France the Nobel Medicine Prize for their discoveries concerning the body’s immune responses.
In a study in Australia, the HPV vaccine Gardasil helped to reduce the number of teenage girls who develop cervical abnormalities by as much as 50 percent.
A new approach developed that uses an adjuvant along with a vaccine shows that newborns may be able to be vaccinated and protected from disease.
Researchers are seeing promising results in animals from a vaccine designed to prevent a heroin high.
A new study is enrolling women who have had exposure to a meningitis vaccine during the first trimester of pregnancy to determine the vaccine’s safety.
Zostavax, the vaccine manufactured by Merck & Co. to prevent shingles, has been approved by the U.S. Food and Drug Administration for adults ages 50 to 59 years old.
The National Vaccine Program Office has developed a new vaccine plan that outlines goals for improving the nation’s vaccine system.
A new monograph from The Joint Commission is intended to help healthcare organizations implement or enhance Tdap vaccination programs.
Health Canada has approved Fluad, a seasonal flu vaccine manufactured by Novartis for adults aged 65 years and older. Fluad is the first seasonal flu vaccine in Canada to contain an adjuvant.